Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Woods

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Movement Ecology|March 18, 2025
Location of capture sufficiently characterises lifetime growth trajectories in a highly mobile fishJoshua S Barrow, Jian D L Yen, John D Koehn, et al.
Plos One|March 9, 2016
Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked ParticipantsNaveed Zafar Janjua, Margot Kuo, Mei Chong, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2008
Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancerW James Morris, Mira Keyes, David Palma, et al.
Frontiers in Oncology|October 31, 2022
Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohortMaryam Darvishian, Terry Tang, Stanley Wong, et al.
Therapeutic Advances in Medical Oncology|February 26, 2021
Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in CanadaMaryam Darvishian, Zahid A Butt, Stanley Wong, et al.
Thorax|July 20, 2021
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 StudyMarzieh Araghi, Miranda Fidler-Benaoudia, Melina Arnold, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP RegistryMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Movement Ecology|March 18, 2025
Location of capture sufficiently characterises lifetime growth trajectories in a highly mobile fishJoshua S Barrow, Jian D L Yen, John D Koehn, et al.
Plos One|March 9, 2016
Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked ParticipantsNaveed Zafar Janjua, Margot Kuo, Mei Chong, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2008
Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancerW James Morris, Mira Keyes, David Palma, et al.
Frontiers in Oncology|October 31, 2022
Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohortMaryam Darvishian, Terry Tang, Stanley Wong, et al.
Therapeutic Advances in Medical Oncology|February 26, 2021
Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in CanadaMaryam Darvishian, Zahid A Butt, Stanley Wong, et al.
Thorax|July 20, 2021
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 StudyMarzieh Araghi, Miranda Fidler-Benaoudia, Melina Arnold, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP RegistryMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Pageof 10